4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0000315066-21-001812
FMR LLC acquired 1,881,355 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-26 | Conversion : show line 1 in the form | +789,473 | 815,788 | I |
| 2021-10-26 | Conversion : show line 2 in the form | +686,499 | 1,502,287 | I |
| 2021-10-26 | Conversion : show line 3 in the form | +28,703 | 1,530,990 | I |
| 2021-10-26 | Conversion : show line 4 in the form | +372,215 | 372,215 | I |
| 2021-10-26 | Conversion : show line 5 in the form | +4,465 | 4,465 | I |
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-26 | Conversion : show line 6 in the form Series A Preferred Stock | −7,500,000 | 0 | I |
| 2021-10-26 | Conversion : show line 7 in the form Series A-1 Preferred Stock | −6,521,739 | 0 | I |
| 2021-10-26 | Conversion : show line 8 in the form Series B Preferred Stock | −272,687 | 0 | I |
| 2021-10-26 | Conversion : show line 9 in the form Series B Preferred Stock | −3,536,046 | 0 | I |
| 2021-10-26 | Conversion : show line 10 in the form Series B Preferred Stock | −42,421 | 0 | I |
Loading xslF345X03/primary_doc.xml…